From $25B to $55B: Moderna’s Melanoma Math
The Phase 3 win validated the platform. Now the harder work begins: manufacturing every dose from scratch.
Business
DAP at $795, Black Sea Shut: Where Fertilizer Fits in the New Wheat Trade
India's export reopening and the Black Sea collapse are redirecting grain flows, but the sharpest opportunity sits in the input…
Micron’s CEO Just Called Time on the Boom-Bust Clock
A $10 billion research lab, a 50% supply shortfall, and a forward P/E of 6.76 are telling three different parts…
The Market Is Pricing NVDA Like a Lender
BofA's FCF math says the discount is real. August 26 decides whether the multiple closes.
Eaton Built a 307-Gigawatt Moat. ETN Still Discounts It
Record Q2 revenue, a 307-gigawatt U.S. pipeline equal to 15 years of build, and a cooling deal running 20% above…
IBM Is Building an AI Delivery OS. OpenAI Is the Latest Module.
The model is not the moat. IBM's Consulting Advantage platform is the real strategic bet, and the OpenAI deal is…
The Fed Is Not the Bond Market’s Biggest Problem
A $29 trillion borrowing wall, a BOJ poised to hike in September, and synchronized fiscal expansion across NATO are pushing…
The Best Earnings Season Since 2008 Is Now the Problem
A record Q2 beat rate has raised the bar so high that even a strong H2 may disappoint.
SMCI Guided Up to $72B. The Cash Flow Hole Is Real.
A fiscal 2027 revenue target 37% above consensus is the headline. Negative $6.8B in operating cash flow is the question…
Washington Owns 30 Tech Stakes. Nobody Can Find the Ledger.
The U.S. has deployed $26.7 billion across chips, AI labs, quantum, and rare earths. The portfolio has no public address.